2008
DOI: 10.1107/s1600536808009240
|View full text |Cite
|
Sign up to set email alerts
|

Eplerenone ethanol solvate

Abstract: Eplerenone [systematic name: 7α-(methoxy­carbon­yl)-3-oxo-9α,11-ep­oxy-17α-pregn-4-ene-21,17-carbolactone], an aldo­sterone receptor antagonist, crystallizes from ethanol as a monosolvate, C24H30O6·C2H6O. The eplerenone mol­ecule has two five-membered rings, three six-membered rings and one three-membered ring. Both five-membered rings display envelope conformations, while the three six-membered rings assume envelope (cyclohexene), half-chair (cyclohexane sharing one edge with epoxy) and chair (other cyclohexa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 9 publications
0
5
0
Order By: Relevance
“…Eplerenone contains sensitive 9,11α-epoxide, 17α-γ-lactone and 7α-carbomethoxy moieties that, depending on the conditions, may hydrolyze or epimerize to afford degradation or epimerization products [ 9 , 10 , 11 , 12 , 13 ]. The SCXRD structure of eplerenone confirms the relative cis configuration of the 9α,11α-epoxide ring and the 7α-carbomethoxy substituent [ 14 , 15 , 16 , 17 ]. Manufacture of eplerenone is always accompanied by side reactions leading to the unwanted impurities that vary with the different starting materials and reaction conditions used.…”
Section: Introductionmentioning
confidence: 88%
“…Eplerenone contains sensitive 9,11α-epoxide, 17α-γ-lactone and 7α-carbomethoxy moieties that, depending on the conditions, may hydrolyze or epimerize to afford degradation or epimerization products [ 9 , 10 , 11 , 12 , 13 ]. The SCXRD structure of eplerenone confirms the relative cis configuration of the 9α,11α-epoxide ring and the 7α-carbomethoxy substituent [ 14 , 15 , 16 , 17 ]. Manufacture of eplerenone is always accompanied by side reactions leading to the unwanted impurities that vary with the different starting materials and reaction conditions used.…”
Section: Introductionmentioning
confidence: 88%
“…The 2008 literature also contained a number of additional reports on the structures and properties of solvatomorphs for various compounds having pharmaceutical interest, and some details of these have been summarized in Table 2 126–141…”
Section: Structural Characterization and Properties Of Polymorphs Andmentioning
confidence: 99%
“…Eplerenone (EP) is a novel selective aldosterone receptor antagonist first developed by Pfizer, which was initially marketed in the US in 2002 for the treatment of hypertension and heart failure. EP, CAS No. 107724-20-9, the systematic name of 9α,11-epoxy-7α-methoxycarbonyl-3-oxo-17α-pregn-4-ene-21,17-carbolactonean, molecular formula: C 24 H 30 O 6 , molecular weight: 414.49 g·mol –1 , is an odorless, white or off-white crystal powder, and its chemical structure and three-dimensional (3D) structure are depicted in Figure . , …”
Section: Introductionmentioning
confidence: 99%
“…107724-20-9, the systematic name of 9α,11-epoxy-7α-methoxycarbonyl-3-oxo-17α-pregn-4ene-21,17-carbolactonean, molecular formula: C 24 H 30 O 6 , molecular weight: 414.49 g•mol −1 , is an odorless, white or offwhite crystal powder, and its chemical structure and threedimensional (3D) structure are depicted in Figure 1. 4,5 As a novel selective aldosterone receptor antagonist, EP has stronger antagonistic effects on aldosterone than spironolactone. Additionally, it exhibits minimal affinity for androgen and progesterone receptors, leading to reduce adverse reactions.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation